Abstract Glucagon-like peptide 1 (GLP-1)-based therapies, such as semaglutide and tirzepatide, represent highly effective treatment options for people with type 2 diabetes and obesity, enabling effective control of glucose and weight loss, while reducing cardiovascular and renal morbidity and mortality
High potassium levels can lead to serious heart problems, making it difficult to manage heart failure effectively
Editor information Editors and Affiliations Rights and permissions Copyright information 2017 Springer International Publishing AG About this entry Cite this entry Stoopler, E.T., Alawi, F
Micronutrient deficiency and muscular status in inflammatory bowel disease
(21, 22) O meta-analiz din 2013 a concluzionat c tratamentul cu L-carnitin au o reducere a mortalitii cu 27%
Several times while playing pickleball, I would have to run off the court and puke